Porter Todd D
Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
J Biochem Mol Toxicol. 2002;16(6):311-6. doi: 10.1002/jbt.10052.
Cytochrome b(5), a 17-kDa hemeprotein associated primarily with the endoplasmic reticulum of eukaryotic cells, has long been known to augment some cytochrome P450 monooxygenase reactions, but the mechanism of stimulation has remained controversial. Studies in recent years have clarified this issue by delineating three pathways by which cytochrome b(5) augments P450 reactions: direct electron transfer of both required electrons from NADH-cytochrome b(5) reductase to P450, in a pathway separate and independent of NADPH-cytochrome P450 reductase; transfer of the second electron to oxyferrous P450 from either cytochrome b(5) reductase or cytochrome P450 reductase; and allosteric stimulation of P450 without electron transfer. Evidence now indicates that each of these pathways is likely to operate in vivo.
细胞色素b(5)是一种主要与真核细胞内质网相关的17 kDa血红素蛋白,长期以来人们已知它能增强某些细胞色素P450单加氧酶反应,但其刺激机制一直存在争议。近年来的研究通过描述细胞色素b(5)增强P450反应的三种途径澄清了这个问题:在一条独立于NADPH - 细胞色素P450还原酶的途径中,将所需的两个电子从NADH - 细胞色素b(5)还原酶直接转移到P450;将第二个电子从细胞色素b(5)还原酶或细胞色素P450还原酶转移到亚铁氧合P450;以及在不进行电子转移的情况下对P450进行变构刺激。现在有证据表明这些途径中的每一种都可能在体内发挥作用。